Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...

The global surgical robots market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

With EU CE mark clearance for LigaSure RAS, Medtronic expands the Hugo system’s capabilities in gynaecologic and urologic ...

Medtronic announced today that it received CE mark for its LigaSure vessel sealing technology for use with its Hugo system.

The article " 5 Robotics Stocks to Buy for the Future of Automation " first appeared on MarketBeat.

HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth.

Medtronic's long-term dividend streak also points to a business capable of performing well over long periods. Healthcare ...

Intuitive Surgical ISRG received the CE-mark for its latest surgical robot system, da Vinci 5, earlier this month. This fifth-generation system includes over 150 enhancements such as Force Feedback ...

Investing in top, market-beating stocks is a great way to generate lucrative returns over the long run. The two companies ...

Wolfe Research analyst Mike Polark recently upgraded Medtronic plc (NYSE:MDT) from Underperform to Peer Perform, citing short-term upside potential while maintaining a cautious long-term outlook.